Clinical Trial Update: A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating veliparib with paclitaxel/carboplatin-based chemoradiotherapy, followed by consolidation, in adults with stage III non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Veliparib (veliparib)

Snippet

Sponsor: AbbVie | Conditions: Non-small Cell Lung Cancer Stage III | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-07-22